Alps Advisors Inc Anavex Life Sciences Corp. Transaction History
Alps Advisors Inc
- $14.5 Billion
- Q2 2024
A detailed history of Alps Advisors Inc transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Alps Advisors Inc holds 66,049 shares of AVXL stock, worth $359,306. This represents 0.0% of its overall portfolio holdings.
Number of Shares
66,049
Previous 57,913
14.05%
Holding current value
$359,306
Previous $294,000
5.44%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AVXL
# of Institutions
152Shares Held
26.5MCall Options Held
674KPut Options Held
811K-
Black Rock Inc. New York, NY6.39MShares$34.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.55MShares$24.7 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$20.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.83MShares$9.96 Million0.0% of portfolio
-
Two Sigma Investments, LP New York, NY1.01MShares$5.51 Million0.01% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $424M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...